Introduction: Every day, at least 1.600 women die worldwide from the complication of Pregnancy and child birth, 90% of which occurring in Asia and Sub Saharan Africa. These shows, maternal death in developing country is higher than developed countries. One of the contributing factors for these problems is cultural malpractices practiced during pregnancy, child birth and post natal periods. The actual incidence of cultural malpractices in developing country accounts for about 5-15% of maternal deaths. The objective of the research was to assess prevalence of cultural malpractice and associated factors among women attending MCH clinic at Debretabor Town governmental health institutions South Gondar, Amhara region North Ethiopia 2015 G.C. Methods:An institution based cross-sectional study was employed. Systematic sampling was used to select 355 study participants. A pre tested and structured questionnaire was used to collect data. The data was entered, cleaned and edited using EPI INFO version 2002 and exported to SPSS version 20 software packages for analysis. Both bivariate and multiple logistic regression were fitted and odds ratio and 95% CI were computed to identify associated factors and determine the strength of association. A p-value of <0.05 was considered as statistical significant.Results: A total of 355 mothers participated with response rate of 100%. The prevalence of cultural malpractice was found to be 25.6%.Ggrand para (AOR 3.466: 1.926, 6.236) was factors significantly associated with cultural malpractice among mothers attended MCH clinic. Conclusion and recommendation:The prevalence of cultural malpractice in the study area was found to be high. Grand shows significant association with cultural malpractice among mothers attended MCH clinic. So, high effort needed to be worked on this target population.

Background: Infection with coronavirus disease (COVID-19) has become a severe public health issue worldwide. A broad amount of information related to the novel coronavirus (COVID-19) pandemic was disseminated by social media in Ethiopia. To date, there is limited evidence on the influence of social media use for covid-19 related information on covid-19 preventive practice. Therefore, this study aimed to assess the influence of social media use on the practice of COVID-19 preventive measures in Ethiopia. Methods: This study employed an anonymous internet-based online cross-sectional survey using Google forms to collects the data from the respondents from 15 May to 17 June 2020 in Ethiopia. Multivariable logistic regression was used to assess the relationship between social media usage as a predictor and COVID-19 preventive practice, after adjusting for socio-demographic and risk perception of COVID-19 variables. The data were analysed using SPSS version 21. Results: A total of 372 respondents have participated in the study. From 372, 208(55.9%) respondents in this study were male. Study participants who had good utilization of social media to get COVID-19 related information were 9.5 times engaged in COVID-19 preventive practices compared to study participants who had poor utilization of social media to get covid-19 related information (AOR= 9.59, 95% CI = 5.70 - 16.13). Also, study participants who had a high-risk perception of COVID-19 were 2.6 times engaged in COVID-19 practices compared to study participants who had a low-risk perception of covid-19 (AOR = 2.63, 95% CI = 1.58 - 4.38). Study participants who were students at the time of this study were four times more likely to show adequate COVID-19 preventive practice score compared to those who had another occupational status (AOR= 4.07, 95% CI= 1.66 - 9.98) Conclusions: Our results show that the usage of social media networks can have a positive effect on the practice of preventive measures and public safety against COVID-19; high-risk perception contributed to preventive activities against COVID-19. Social networking platforms can be used by public health agencies as an important method to raise public health understanding by disseminating concise messages to targeted audiences.

Background: The primary goal of antiretroviral therapy is to prevent human immune deficiency virus (HIV)-related morbidity and mortality. Deferring antiretroviral therapy (ART) until CD4 counts decline puts individuals with HIV at risk of HIV-related morbidity and mortality. Objective: This study aims to assess the effect of the test and treat strategy on mortality among HIV-positive clients on ART in public hospitals in Addis Ababa. Methods: A retrospective cohort study was conducted at five selected public hospitals in Addis Ababa. A cohort of 216 ART clients taken as an exposed group (test and treat" strategy) from 2017 to 2019 and 216 ART clients as an unexposed group taken from 2014 to 2017; totally, 432 clients were included in the study. Multivariate Cox regression was used to estimate the effect of the test and treat strategy on the survival of ART clients adjusting for other covariates. Results: The 432 clients contributed to a total of 1025.17 person-years follow-up. Ninetyone (21.06%) of them died, 14.3% were unexposed and 6.7% were exposed (test and treat). The incidence of death was 92.4 and 81.8/1000 person-years in the unexposed group and exposed group, respectively, with an overall mortality rate of 88.8/1000 person-years. Besides, test and treat strategy (AHR: 0.31; 95% CI: 0.19, 0.52), baseline CD4 counts >350 cells/mm3 (AHR 0.40; 95%: CI: 0.20, 0.80), bedridden functional status (AHR 2.46; 95% CI: 1.41, 4.27), poor adherence (AHR 3.25; 95% CI: 1.410-7.51), moderate malnutrition on last visit (AHR 2.56; 95% CI: 1.30-5.04) and staying on original regimen (AHR 4.68; 95% CI 2.72, 8.07) were independent predictors of mortality. Conclusion: Mortality among HIV patients on treatment decreased significantly since the start of the test and treat strategy. Therefore, test and treat strategy should be strengthened in all public and private facilities throughout the country.

Low vaccine acceptance remains a public health threat, which is still common among healthcare workers. Therefore, the purpose of this review is to determine the level of COVID-19 vaccine acceptance among healthcare professionals in Ethiopia. This review was reported using the PRISMA checklist. Eleven articles were retrieved, then extracted on Excel, and exported to STATA version 11 software for meta-analysis. The pooled prevalence of vaccine acceptance and it is 95% CI were presented using forest plots. Tests to check heterogeneity and publication bias were done. The estimated pooled prevalence of COVID-19 vaccine acceptance among healthcare professionals in Ethiopia with a random-effects model was 54.59% (95% CI: 42.49, 66.69) through a heterogeneity index (I 2 ) of 99.1% ( p < .001), which is relatively low. Therefore, it is important to identify and remove any myths or obstacles preventing healthcare professionals from accepting the COVID-19 vaccination.

BackgroundBurden of HIV/AIDS is high in low- and middle-income countries including Ethiopia. In resource-poor countries like Ethiopia, the survival of patients with AIDS treated with ART depends on a variety of factors, which may also vary greatly with economic, demographic, behavioral risk, and health factors. Unlike other previous studies, this study was done at health centers since some of the clinical factors may differently affect the survival of the patients under ART. ObjectivesThe main aim of this study is to estimate the mortality rate and survival predictors among adult HIV infected patients under ART at health centers in Kirkos sub city.MethodA retrospective cohort study was conducted at the health centers found in Kirkos sub-city, Addis Ababa. All adult HIV positive patients under follow-up between Dec. 1, 2014, and Oct. 30, 2019 were the source population. A total of 665 samples were taken using the lottery method. Data were extracted from the patient card and electronic database by trained data collectors. Kaplan-Meier and Cox-proportional hazard regressions were used. Resulta total of 55(8.5%) of death has occurred with the incidence death of 3.25/100 person-years. Majority of deaths occurring within 6 months of ART initiation. Predictors mortality were patients with age category above 50 years (AHR = 4.90, 95% CI: 2.00, 11.98), TB comorbidity (AHR= 3.46, 95% CI: 1.52,7.91), WHO stage IV (AHR = 4.55,95% CI: 1.72,12.02), lack of dug adherence (AHR=1.76, 95% CI: 1.23, 3.33), co-trimoxazole therapy (AHR=2.56, 95% CI: 1.25,5.24),BMI of less than 18.5 (AHR= 2.59, 95% CI: 1.37,4.90) and CD4 cell count, below 200/dl (AHR =22.77, 95% CI: 1.30,5.92).ConclusionThe majority of deaths occurring within six months of ART initiation. Factors directly or indirectly affects immunity were associated with poor survival. Prevention of TB infection, enhancing feeding and early screening of nutritional status of patients’ needs great attention.

Pregnancies in the bicornuate uterus are usually considered high-risk because of their association with poor reproductive outcomes such as recurrent pregnancy loss, cervical insufficiency, low birthweight, preterm birth, malpresentation, cesarean delivery, and uterine rupture. The objective of the report was to show that patients with a scared bicornuate uterus at post-term could have successful pregnancy outcomes. We are presenting a 28-year-old gravida III para II lady with a bicornuate scared uterus at post-term. She has a history of early third-trimester pregnancy loss, and her second pregnancy was delivered via cesarean section. In her first pregnancy, the patient's uterus was not identified as bicornuate. However, an ultrasound during her second pregnancy revealed that she had a bicornuate uterus, which led to the diagnosis. At term, the lady had a successful cesarean section. Lastly, for the current post-term pregnancy she had no prenatal check-up. Even though this, she was coming at the latent first stage of labor and an emergency cesarean section was done.Conclusion Successful outcomes could be achieved in patients with the bicornuate uterus at post-term gestation.

No abstract

Introduction. In resource-limited settings such as Ethiopia, where the prevalence of HIV/AIDS is high, a number of factors, including economic, demographic, behavioral risk, and health factors, affect how long people with AIDS are treated with antiretroviral therapy. Since several aspects of the clinical setup may have an impact on ART patients’ survival, this study was conducted in health centers. Determining the mortality rate and survival factors among adult HIV-infected patients receiving ART at health centers in Addis Abeba’s Kirkos subcity is the primary goal of this study. Methods. A retrospective cohort study was carried out at the health center in Addis Abeba’s Kirkos subcity. The source population consisted of all adult HIV-positive patients who were being followed up between December 1, 2014, and October 30, 2019. A total of 665 samples were collected using a computer-generated simple random sampling method in each of the three health centers that were chosen by a lottery system depending on the number of patients in the follow-up. Trained data collectors took the information out of the patient card and the electronic database. Regressions using the Kaplan‐Meier and Cox proportional hazards were employed. Results. The incidence of death rate in adult HIV-positive patients was 55 (8.5%) fatalities, translating to a death rate of 3.25 per 100 person-years. The majority of deaths occurred within 6 months of ART initiation. Predictors of mortality were: age above 50 years (AHR = 4.90, 95% CI: 2.00, 11.98), tuberculosis comorbidity (AHR = 3.46, 95% CI: 1.23, 3.33), lack of drug adherence (AHR = 1.76, 95% CI: 1.23, 3.33), co-trimoxazole therapy (AHR = 2.59, 95% CI: 1.37, 4.90), and CD4 cell count less than 200/dl (AHR = 2.77, 95% CI: 1.30, 5.92). Conclusion and Recommendation. Adult HIV-positive individuals had an incidence of the death rate of 55 (8.5%), which equates to 3.25 deaths per 100 person-years. Age category over 50, TB comorbidity, WHO stage IV, lack of medication adherence, co-trimoxazole therapy, body mass index under 18.5 kg/m2, and CD4 cell count under 200/dl were predictors of mortality. Therefore, it is important to focus on prevention, early identification, and treatment of HIV/AIDS for these predictors at all levels of the HIV/AIDS chronic care package in order to increase survival.